SPOTLIGHT -
The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.
Study Shows Dapagliflozin Effective Against Chronic Kidney Disease
The investigators also found the effects of dapagliflozin were similar in patients with type 2 diabetes and those without type 2 diabetes.
Alan S. Kliger: Treating Kidney Diseases During COVID-19
Nephrologists have used telemedicine tools to help treat patients during the pandemic.
Alan S. Kliger, MD: Negative COVID-19 Outcomes Common in Kidney Disease Patients
A high proportion of end-stage kidney disease patients have suffered severe COVID-19 outcomes.
Investigators Identify Key Component in COVID-19, Kidney Injury Link
The highest suPAR tertile was linked to a 9.15-fold increase in the odds of an acute kidney injury.
No Cardiovascular Benefit from Phosphate Binders in Chronic Kidney Disease Patients
Lanthanum is commonly prescribed to CKD patients to help reduce the risk of bone and cardiovascular disease.
Non-Invasive Test to Detect and Monitor for Liver Disease Among Veterans Signals Clinical Trend for All Americans
This article is the second in a series of four articles exploring the epidemic of liver disease called nonalcoholic fatty liver disease and its more severe form, nonalcoholic steatohepatitis.
Data Shows TB Incidence Rate in Post-Renal Transplant Population
Of the 2199 patients who received a renal transplant, only 8 were treated for active tuberculosis.
Researchers Identify More Risk Factors for Chronic Kidney Disease Progression
For patients without diabetes, low serum bicarbonate and higher high sensitivity troponin T, NTproBNP, and urine NGAL were linked to a higher risk of the composite outcome.
Researchers Breakdown Race and Ethnicity Data for End-Stage Kidney Disease
Racial and ethnic disparities did not substantially improve between 2005-2015 for patients with end-stage kidney disease.
Specific Drugs Yield More Adverse Reactions for Chronic Kidney Disease Patients
Antithrombotic agents caused 34% of serious adverse drug reactions identified in the study.
FDA Sends Complete Letter Response for Veverimer to Treat Metabolic Acidosis
Tricida will meet with the FDA in an attempt to provide more data for the treatment of patients with chronic kidney disease.
No Cardiovascular Benefit From Vitamin K Supplementation for Chronic Kidney Disease Patients
There were no differences found in pulse wave velocity, augmentation index, or physical function between patients who took vitamin K supplements and patients given a placebo.
Investigators Quantify Serum Creatinine Baseline Definition Impact on Mortality
Categorizing baseline SCr as the median value over the preadmission period could be the least biased estimate of the baseline renal function.
Study Results Show Benefit for Daratumumab-CyBorD Treatment for AL Amyloidosis
Investigators find study drug was well-tolerated with no new safety concerns.
New Algorithm Helps Predict Likelihood of Acute Kidney Injuries
Less than 1% of nearly 500,000 hospitalized patients required kidney replacement therapy.
Larger eGFR Declines Could Improve Effectiveness of Canagliflozin
Canagliflozin is a known treatment for kidney disease, as well as heart failure in patients with type 2 diabetes and diabetic nephropathy.
Investigators Identify Demographic Trends for Chronic Kidney Disease
There is a higher chronic kidney disease prevalence for individuals with lower educational levels.
New Report Highlights National COVID-19 Patient Characteristics
Chronic kidney disease and kidney failure represent the most common comorbidities for patients hospitalized with COVID-19 infections.
Albumin-Creatinine Ratio Better for Chronic Kidney Disease Screening
The estimated two-year four-variable kidney failure risk equation for individual risk using predicted ACR from PCR had discrimination similar to that of using observed ACR.
Initial eGFR Decline with Empagliflozin Has No Impact on Reduction in CV Death
Silvio Inzucchi, MD, discusses an EMPA-REG OUTCOME analysis assessing the impact of empagliflozin in patients who experience an initial dip in eGFR.
eGFR Could Serve as Biomarker for Increased CVD Risk in Healthy Individuals
New research is shining light on the use of eGFR as a biomarker for increased cardiovascular risk.
FDA Approves New Intravenous Triferic Formulation
The intravenous approach can be used regardless of what bicarbonate delivery method a dialysis center uses.
ACC House Call: Current SGLT-2 Inhibitor Standing
A discussion with a Brigham and Women's Hospital cardiologist on the research of the add-on cardiometabolic drug class.
Not All IBD Medications Linked to Increased Kidney Disease Risk
Azathioprine is linked to a slightly higher eGFR for patients with inflammatory bowel disease.
Chronic Kidney Disease a Precursor to Heart Disease
Coronary microvascular dysfunction is independently related to abnormal cardiac mechanics, according to a new study.
Proteinuria Levels Predict Future Kidney Function Loss
Higher ACR levels following an acute kidney injury is linked to an increased risk of kidney disease progression.
Better Predictors for Graft Failure in Kidney Recipients
In a new study, investigators determine the death-censored risk of graft failure with structural kidney feature.
Investigators Suggest Expanding Donor Pool with Discarded Kidneys
Deceased donor kidneys could offer a solution to a major kidney shortage in the US.
Coffee Consumption Promotes Better Kidney Function
In a new study, investigators suggest coffee may be used in prevention strategies for chronic kidney disease.
Jeffrey Berger, MD: Key Differences in ISCHEMIA and ISCHEMIA-CKD Results
Discussing the key differences in the results of ISCHEMIA and ISCHEMIA-CKD, which examined whether the use of invasive or conservative strategies was more effective for patients with ischemic heart disease.